In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared ...
Research findings from the I-STOP-AF Trial, presented at the American Heart Association’s Scientific Sessions 2021, ...
A study, presented at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2021, ...
According to an analysis of 10 years of medical data presented at the American Heart Association’s Scientific Sessions ...
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.